Evaluating a Digital Cognitive Training Intervention in Adults With ADHD (NCT07050225) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluating a Digital Cognitive Training Intervention in Adults With ADHD
52 participantsStarted 2025-08
Plain-language summary
The goal of this clinical trial is to evaluate whether a digital cognitive training program can reduce symptoms of ADHD, improve executive functioning, and decrease problematic internet use in adults aged 18-65 with a diagnosis of moderate to severe ADHD. The main questions it aims to answer are:
Can digital cognitive training improve executive function, and ADHD symptoms in adults with ADHD?
Does digital cognitive training reduce problematic internet use in this population?
Researchers will compare the digital cognitive training intervention group to a non-cognitive training digital platform to see if the training leads to greater improvements in cognitive and behavioral outcomes.
Participants will:
Complete an 11-week digital cognitive training program (3, 1-hour sessions/week) or placebo intervention (3, 1-hour sessions/week)
Attend baseline, midpoint, and post-intervention assessments
Participate in weekly check-ins to monitor engagement and tolerability
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants must provide informed consent and agree to comply with study protocols for the duration of the study.
* Participants must be fluent in speaking and reading English and able to complete rating scales and assessments.
* Participants must be adults aged 18-65 years.
* Participants must have a clinical diagnosis of ADHD based on DSM-5 Criteria, as confirmed by the Mini Neuropsychiatric interview.
* Participants being treated with pharmacotherapy must be stable and on a consistent dose for at least 6 weeks prior to study entry.
* Participants must have access to a computer capable of running the cognitive training platform.
* Participants must be comfortable operating a computer and be able to log on to the platform without assistance.
Exclusion Criteria:
* Exclude individuals who meet DSM-5 criteria for psychiatric conditions such as borderline personality disorder, schizophrenia, severe depression, or other psychotic disorders as well as neurological conditions such as epilepsy, dementia, and amnesia, that may interfere with cognitive training.
* Exclude participants with active substance use disorders.
* Exclude participants receiving behavioral therapy or undergoing similar cognitive training programs for ADHD and/or PIU.
* Exclude individuals with severe visual, auditory, or motor impairments that affect the ability to perform the digital cognitive training intervention.
* Exclude participants who are uncomfortable using applications or r…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of participants who prematurely withdraw from the study protocol
Timeframe: From enrollment to the end of treatment at 11 weeks
2
The feasibility of digital cognitive training on ADHD symptoms in adults diagnosed with ADHD of moderate-severe severity
Timeframe: From enrollment to the end of treatment at 11 weeks